Kyntra Bio, Inc. (KYNB) revenue

Revenue · fiscal 2025
$6.44M

Kyntra Bio, Inc. (KYNB) reported revenue of $6.44M in fiscal 2025 (the year ended December 31, 2025). That is 78.3% lower than the $29.62M of fiscal 2024. Figures as of 18 Nov 2026, 11:26 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$6.44M
Change on fiscal 2024
−78.3%
Growth, 5 years
−48.4% a year
Growth, 10 years
−28.4% a year
Highest on record
$256.58Mfiscal 2019
Lowest on record
$6.44Mfiscal 2025
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Kyntra Bio, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 48.4% a year; over ten years the rate was −28.4% a year. Across the 13 fiscal years on record (2013–2025), the highest was $256.58M in fiscal 2019 and the lowest $6.44M in fiscal 2025.

History · 13 fiscal years

Revenue by fiscal year

Kyntra Bio, Inc. revenue, year by year

Kyntra Bio, Inc. (KYNB) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$6.44M 78.3% down
2024$29.62M 36.7% down
2023$46.80M 66.7% down
2022$140.73M 40.2% down
2021$235.31M 33.5% up
2020$176.32M 31.3% down
2019$256.58M 20.5% up
2018$212.96M 62.6% up
2017$131.00M 28.5% down
2016$183.19M 1.3% up
2015$180.83M 31.4% up
2014$137.60M 34.7% up
2013$102.17M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on KYNB

Kyntra Bio, Inc., figure by figure

Kyntra Bio, Inc. (KYNB) overview: price, valuation and scorecard

Kyntra Bio, Inc. revenue: questions and answers

What is Kyntra Bio, Inc.'s revenue?

Kyntra Bio, Inc. (KYNB) reported revenue of $6.44M in fiscal 2025 (the year ended December 31, 2025). That is 78.3% lower than the $29.62M of fiscal 2024.

What is the growth rate of Kyntra Bio, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 48.4% a year; over ten years the rate was −28.4% a year.

What are the highest and lowest revenue figures on record for Kyntra Bio, Inc.?

Across the 13 fiscal years on record (2013–2025), the highest was $256.58M in fiscal 2019 and the lowest $6.44M in fiscal 2025.

How is Kyntra Bio, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Kyntra Bio, Inc. it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kyntra Bio, Inc. (KYNB) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/KYNB/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.